Assessing long-term effectiveness of MS treatment — a matter of debate

No abstract is available for this paper.

• Publication year

  2021

• Venue

  Nature Reviews Neurology

• Publication date

  2021-02-25

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/s41582-021-00476-xPMID 33633380
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cumulative effects of therapies on disability in relapsing multiple sclerosis

  2021cited by this paper
• Effect of Disease Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years.

  2020cited by this paper
• Has the Time Come to Revisit Our Standard Measures of Disability Progression in Multiple Sclerosis?

  2020cited by this paper
• Leveraging real-world data to investigate multiple sclerosis disease behavior, prognosis, and treatment

  2019cited by this paper
• Observatoire Français de la Sclérose en Plaques (OFSEP): A unique multimodal nationwide MS registry in France

  2018cited by this paper
• Treatment decisions in multiple sclerosis — insights from real-world observational studies

  2017cited by this paper
• Practice of Epidemiology Marginal Structural Cox Models for Estimating the Association Between β-Interferon Exposure and Disease Progression in a Multiple Sclerosis Cohort

  2014cited by this paper
• Marginal structural Cox models for estimating the association between β-interferon exposure and disease progression in a multiple sclerosis cohort.

  2014cited by this paper
• Flexible modeling of the cumulative effects of time‐dependent exposures on the hazard

  2011cited by this paper
• Flexible modeling of the cumulative effects of time‐dependent exposures on the hazard

  2009cited by this paper
• Modeling cumulative dose and exposure duration provided insights regarding the associations between benzodiazepines and injuries.

  2006cited by this paper
• Marginal Structural Models and Causal Inference in Epidemiology

  2000cited by this paper

• Knowledge Graph-Guided Identification of Multiple Sclerosis and Therapeutic Trend Analysis: Real-World Evidence from Two Large Healthcare Systems

  2025cites this paper
• Paradigm shifts: Early initiation of high-efficacy disease-modifying treatment in multiple sclerosis

  2021cites this paper